SARS‑CoV‑2-induced remission of advanced classical Hodgkin lymphoma.
作者信息
Kurlapski Michał, Romanowicz Grzegorz, Taszner Michał, Zaucha Jan M
机构信息
Department of Hematology and Transplantology, Medical University of Gdansk, Gdańsk, Poland
Department of Nuclear Medicine, Medical University of Gdansk, Gdańsk, Poland
出版信息
Pol Arch Intern Med. 2022 Aug 22;132(7-8). doi: 10.20452/pamw.16266. Epub 2022 May 25.
PMID:35620893
Abstract
摘要
相似文献
1
SARS‑CoV‑2-induced remission of advanced classical Hodgkin lymphoma.
Pol Arch Intern Med. 2022 Aug 22;132(7-8). doi: 10.20452/pamw.16266. Epub 2022 May 25.
2
SARS-CoV-2-induced remission of Hodgkin lymphoma.严重急性呼吸综合征冠状病毒2型诱导霍奇金淋巴瘤缓解
Br J Haematol. 2021 Feb;192(3):415. doi: 10.1111/bjh.17116. Epub 2021 Jan 2.
3
Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review).新冠病毒与癌症的相关性：致癌还是抗癌？（综述）。
Int J Oncol. 2022 Apr;60(4). doi: 10.3892/ijo.2022.5332. Epub 2022 Mar 2.
4
SARS-CoV-2-neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphoma.严重急性呼吸综合征冠状病毒2中和抗体治疗新型冠状病毒肺炎合并B细胞非霍奇金淋巴瘤所致免疫缺陷患者
Blood Adv. 2022 Mar 8;6(5):1580-1584. doi: 10.1182/bloodadvances.2021006655.
5
Low-dose pembrolizumab induced remission in patients with refractory classical Hodgkin lymphoma.低剂量派姆单抗可诱导难治性经典型霍奇金淋巴瘤患者缓解。
Br J Haematol. 2017 Jan;176(1):131-132. doi: 10.1111/bjh.13920. Epub 2016 Jan 15.
6
Classical Hodgkin lymphoma-like post-transplant lymphoproliferative disease after allogeneic stem cell transplantation for primary myelofibrosis is successfully treated with nivolumab: A case report.异基因造血干细胞移植后发生类似于经典型霍奇金淋巴瘤的移植后淋巴组织增生性疾病，成功接受纳武利尤单抗治疗：一例报告。
J Oncol Pharm Pract. 2021 Mar;27(2):509-512. doi: 10.1177/1078155220946462. Epub 2020 Aug 6.
7
Isolated post SARS‑CoV‑2 diplopia.新型冠状病毒肺炎后孤立性复视
J Neurol. 2021 Feb;268(2):391. doi: 10.1007/s00415-020-10072-6. Epub 2020 Jul 18.
8
Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma.当代治疗经典疾病的选择：晚期霍奇金淋巴瘤。
Crit Rev Oncol Hematol. 2020 Apr;148:102897. doi: 10.1016/j.critrevonc.2020.102897. Epub 2020 Feb 13.
9
Resurgence of Covid-19 pandemic: Challenging situation of economics vs. healthcare.新冠疫情的卷土重来：经济与医疗保健的严峻挑战局面。
Scott Med J. 2021 Feb;66(1):1-2. doi: 10.1177/0036933020973913.
10
Population Pharmacokinetics and Exposure - Safety Analyses of Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma.纳武利尤单抗治疗复发或难治性经典型霍奇金淋巴瘤患者的群体药代动力学和暴露-安全性分析。
J Clin Pharmacol. 2019 Mar;59(3):364-373. doi: 10.1002/jcph.1324. Epub 2018 Oct 19.
引用本文的文献
1
De novo AML spontaneously achieved PR after COVID-19 infection, and CR after reduced dose of azacytidine combined with venetoclax: A case report and literature review.初发急性髓系白血病在新冠病毒感染后自发达到部分缓解，在低剂量阿扎胞苷联合维奈克拉治疗后达到完全缓解：一例病例报告及文献综述
Medicine (Baltimore). 2025 Apr 25;104(17):e42039. doi: 10.1097/MD.0000000000042039.
2
Spontaneous remission of a pulmonary sclerosing epithelioid fibrosarcoma: a case report of a possible abscopal effect.肺硬化性上皮样纤维肉瘤的自发缓解：一例可能存在远隔效应的病例报告
Transl Cancer Res. 2024 May 31;13(5):2564-2570. doi: 10.21037/tcr-23-2276. Epub 2024 May 21.
3
Tumor reduction after SARS‑CoV‑2 infection in a patient with lung cancer: A case report.一名肺癌患者感染新型冠状病毒后肿瘤缩小：病例报告
Oncol Lett. 2024 Feb 22;27(4):169. doi: 10.3892/ol.2024.14302. eCollection 2024 Apr.
4
Tumor lysis syndrome followed by tumor regression after COVID-19 in a patient with chronic lymphocytic leukemia.一名慢性淋巴细胞白血病患者在感染新冠病毒后出现肿瘤溶解综合征，随后肿瘤消退。
Int Cancer Conf J. 2023 Aug 23;13(1):22-25. doi: 10.1007/s13691-023-00631-9. eCollection 2024 Jan.
Zotero 插件